Risedronate for the prevention and treatment of postmenopausal osteoporosis

  • Withdrawn
  • Review
  • Intervention


  • A Cranney,

  • JD Adachi,

  • G Guyatt,

  • A Papaioannou,

  • VA Robinson,

  • BJ Shea,

  • P Tugwell,

  • LM Waldegger,

  • B Weaver,

  • G Wells,

  • N Zytaruk

Dr Ann Cranney, Division of Rheumatology, Ottawa Hospital, 1053 Carling Ave, Ottawa, Ontario, K1Y 4E9, CANADA. ancranney@ohri.ca.

Reason for withdrawal from publication

Cochrane Funding Arbitration panel recommended withdrawal of this review.